Active, not recruitingPhase 1NCT06514898

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Studying Medulloblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Florida
Principal Investigator
Duane Mitchell, MD, PhD
University of Florida
Intervention
TTRNA-DC vaccines with GM-CSF(biological)
Enrollment
12 target
Eligibility
4-30 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

Children's National Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06514898 on ClinicalTrials.gov

Other trials for Medulloblastoma

Additional recruiting or active studies for the same condition.

See all trials for Medulloblastoma

← Back to all trials